Navigation Links
Thailand To Procure Botulism Antitoxin Internationally

BANGKOK - Thailand has received emergency shipments of botulism antitoxin from Canada, England and the United States after an outbreak of the disease// in which more than 100 villagers in Thailand's northern Nan province contacted botulism after they consumed contaminated bamboo shoots prepared in a traditional manner.

Thawat Suntrajarn, the head of Thailand's Disease Control Department, said that 168 villagers contracted botulism, which is a rare but often fatal neuromuscular disease. 143 patients were admitted to hospital, among whom 33 needed life support. Thawat said that the number of cases reported was the largest in Thailand and perhaps the world. The Ministry of Public Health and the World Health Organization (WHO) had asked for international aid agencies to procure the anti-toxin from various countries. Thailand is also trying to secure it from Japan. Thailand's early response was possible since a Ministry of Public Health team was in a nearby area conducting research on chronic liver cancer.
'"/>




Page: 1

Related medicine news :

1. Thailand had Fewer AIDS-Related Deaths, New HIV Cases In 2005
2. Botulism Scare in Thailand Shakes US
3. Thailand To Test Efficacy Of Stem Cell Technology
4. Thailand to Explore Stem Cell Technology for Treatment of Heart Disease
5. People In Thailand Not Bothered About Bird Flu
6. Thailand Tops in Rare Type of Cancer
7. Bird Flu in Thailand Suspected to be H5N1 Strain
8. Forty-Six Suspected Bird Flu Cases In Thailand
9. Screening of bird flu patients by pharmacies in Thailand
10. Thailand May Seek Help Of Pharmacies For Screening Bird Flu
11. Greenpeace takes legal action against Thailand over GM crop

Post Your Comments:
(Date:11/25/2009)...toImproveOverallOutcomesforLungCancer ,, WASH...CancerAlliance-California(LCA-CA)issuedits2ndAnnua...essmentofprogressbeingmadeagainstthislethaldisease...rAlliance(LCA),theonlynationalorganizationdedicate...vingwithoratriskforlungcancer. ,, (Photo: http:...
(Date:11/25/2009)... and Spanish . , , Researchers from the ...gnosis of certain ocular diseases that are very co...on and keratitis, by applying an existing optical ...n used for this purpose. , Scientists from the ...fected by one of these two pathologies, finding a ...
(Date:11/25/2009).... Kaplan, MD, FACP, a former Board Chair and one o...me Los Angeles Biomedical Research Institute at Ha...red by the American College of Physicians for his ...its April 22, 2010 meeting in Toronto, the America...th the Ralph O. Claypoole Sr. Memorial Award for D...
(Date:11/25/2009)... . , An innovative treatment for HIV patient...earchers has passed its first clinical trial with ...py customized for each individual patient, and was...titute of the MUHC in collaboration with Dr. R. Sk...ine made for the individual patient an "haute cou...
(Date:11/25/2009)...o new drugs for people, researchers say , ...dienes, natural lipid molecules found in soy, coul...cancer, California researchers have found. , T... pointed out that they could help explain why soy ..., In the study, Dr. Julie Saba, senior scientis...
Breaking Medicine News(10 mins):Health News:Lung Cancer Alliance-California Releases 2nd Annual State-Specific Report Card On Lung Cancer 2Health News:Achieve early diagnosis of ocular pathologies such as keratitis and macular degeneration 2Health News:1 of LA BioMed's founders to be honored 2Health News:Tailor-made HIV/AIDS treatment closer to reality 2Health News:Natural Soy Component May Help Treat Colon Cancer 2
...rs could provide scientific baseline for anti-agin...ov. 19 (HealthDay News) -- Genetic biomarkers that...age have been identified by researchers at Califor...ode worms, microarrays that measure changes in gen...
... Cancer Society urges people to stop for a day, th...Day News) -- Everyone knows smoking is bad for you...rs for Disease Control and Prevention said that th...h levels of smoking-related health problems, death...
...E, Calif., Nov. 19 Accuray Incorporated,(Nasdaq: ...gery, announced today,that on November 14, 2008, t...,Market stating that it is not in compliance with ...2008. , Within 60 calendar days following re...
...ve approach could aid research, treatment, experts...s) -- U.S. researchers say they,ve developed a new...urvival of cancer-killing cells within the body. ,...m Stanford University School of Medicine reports. ...
... Tenn., Nov. 19 Arabesque, an imprint of Kimani P...00 to St. Jude Children,s Research Hospital(R) in ...ove & Hope. The donation was presented recentl...thors Sandra Kitt and Gwynne Forster attended to a...
...kthrough Technology Leaves Skin Consistently Smoot... 18 Body-sculpting technology with consistently s... has launched in the U.S. and is now available to ...po is a laser device for minimally invasive laser-...
Other Medicine News:Health News:Researchers ID Suite of Genes in Aging Process 2Health News:Smokeout '08: The Perfect Time to Quit 2Health News:Smokeout '08: The Perfect Time to Quit 3Health News:Smokeout '08: The Perfect Time to Quit 4Health News:Accuray Receives Nasdaq Notification Related to the Late Filing of Form 10-Q 2Health News:Accuray Receives Nasdaq Notification Related to the Late Filing of Form 10-Q 3Health News:Accuray Receives Nasdaq Notification Related to the Late Filing of Form 10-Q 4Health News:Technique Tracks Cancer-Killing Cells 2Health News:Arabesque Books Donates $15,000 in Support of St. Jude in Conjunction With a New Fall Book Series 2Health News:Eleme Medical Launches SmoothLipo(TM) Body Shaping Treatment 2
(Date:11/25/2009)...FirstCall/--Abaxis,Inc.(Nasdaq: ABAX ),amedicalpro...ssystems,announcedtodaythatClintSeverson,chairmana...PiperJaffrayHealthCareConferenceonWednesday,Decemb...ewYorkPalaceHotelinNewYorkCity. ,, AboutAbaxis...blebloodanalysissystemsforuseinanyveterinaryorhuma...
(Date:11/25/2009)...l/--NuVasive,Inc.(Nasdaq: NUVA ),amedicaldevicecom...ivesurgicaltreatmentsforthespine,announcedtodaytha...,at5:30p.m.ET/2:30p.m.PT.Theconferencecallwillfocu...ny,sproductsandwillincludecommentsfrommanagementfo...umbersare1-877-407-4018fordomesticcallersand1-201-...
(Date:11/25/2009)...inker.comannouncesthatanewmarketresearchreportisav...ry-USMarketTrends&Analysis http://www.reportl...arket-Trends--Analysis.html ,, TheUSintranasal...uticapplicationsfromthedeliveryofconventionallocal...drugs.Thefutureofthetechnologyhingesontotheeffecti...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5IncentOne Announces New Incentive Wrap Around to Increase Participation in Multi Flu Prevention Programs 52262 1IncentOne Announces New Incentive Wrap Around to Increase Participation in Multi Flu Prevention Programs 52262 2First Anniversary of New War on Cancer Marks Many Advances 52259 1First Anniversary of New War on Cancer Marks Many Advances 52259 2First Anniversary of New War on Cancer Marks Many Advances 52259 3First Anniversary of New War on Cancer Marks Many Advances 52259 4First Anniversary of New War on Cancer Marks Many Advances 52259 5First Anniversary of New War on Cancer Marks Many Advances 52259 6First Anniversary of New War on Cancer Marks Many Advances 52259 7Anti epilepsy drug risk on cognitive function for unborn children 52256 1Anti epilepsy drug risk on cognitive function for unborn children 52256 2
...th ("Radius"),announced today that the company has...s internal nonsteroidal selective androgen recepto...reclinical development as a,potential therapy for ...ia),and other musculoskeletal conditions such as o...of promising SARMs after it demonstrated exception...
...peutics,Inc. (Nasdaq: HALO ), a biopharmaceutical...argeting the extracellular matrix, today,announced...tus program at,the American Diabetes Association,s...mbining the company,s proprietary recombinant huma... (regular insulin human) or,Humalog(R) (insulin li...
Other Medicine Technology:Radius Selects First Preclinical Candidate From SARM Discovery Program for the Treatment of Muscle Loss and Other Musculoskeletal Conditions 2Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability 2Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability 3Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability 4Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability 5
Optima 38/SP
Optima FW
Hertel
Exophthalmometer, Hertel
Medicine Products: